HOME >> BIOLOGY >> NEWS
Biology behind homosexuality in sheep, study confirms

PORTLAND, Ore. Researchers in the Oregon Health & Science University School of Medicine have confirmed that a male sheep's preference for same-sex partners has biological underpinnings.

A study published in the February issue of the journal Endocrinology demonstrates that not only are certain groups of cells different between genders in a part of the sheep brain controlling sexual behavior, but brain anatomy and hormone production may determine whether adult rams prefer other rams over ewes.

"This particular study, along with others, strongly suggests that sexual preference is biologically determined in animals, and possibly in humans," said the study's lead author, Charles E. Roselli, Ph.D., professor in the Department of Physiology and Pharmacology, OHSU School of Medicine. "The hope is that the study of these brain differences will provide clues to the processes involved in the development and regulation of heterosexual, as well as homosexual, behavior."

The results lend credence to previous studies in humans that described anatomical differences between the brains of heterosexual men and homosexual men, as well as sexually unique versions of the same cluster of brain cells in males and females.

"Same-sex attraction is widespread across many different species." said Roselli, whose laboratory collaborated with the Department of Animal Sciences at Oregon State University and the USDA Agricultural Research Service's U.S. Sheep Experiment Station in Dubois, Idaho.

Kay Larkin, Ph.D., an OHSU electron microscopist who performed laboratory analysis for the study, said scientists now have a marker that points to whether a ram may prefer other rams over ewes.

"There's a difference in the brain that is correlated with partner preference rather than gender of the animal you're looking at," she said.

About 8 percent of domestic rams display preferences for other males as sexual partners. Scientists don't believe it's r
'"/>

Contact: Jonathan Modie
modiej@ohsu.edu
503-494-8231
Oregon Health & Science University
8-Mar-2004


Page: 1 2 3

Related biology news :

1. NIGMS funds Center for Quantitative Biology
2. Biology of aging
3. Chemistry meets Biology
4. Annual Chemical Biology Symposium at Yale May 14, 2004
5. Institute for Systems Biology, Pacific Northwest National Laboratory announce collaboration
6. Light Biology, a biotech company based on UT Southwestern technology, bought by NimbleGen Systems
7. Biochemistry and Molecular Biology: Research at the Interface of Biochemistry and Human Health
8. Experimental Biology 2004 - Translating the Genome
9. ASPB Plant Biology 2004 in Walt Disney World
10. The American Society for Biochemistry and Molecular Biology meets in Boston
11. Experimental Biology 2004 meets in Washington, D.C. April 17-21

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biology behind homosexuality sheep study confirms

(Date:5/14/2015)... May 14, 2015  Verificient Technologies, Inc., ... and online remote proctoring, announced a new ... company and creator of the Canvas Learning ... two companies will benefit from the seamless ... As a fully integrated multifactor biometrics ...
(Date:5/11/2015)... Ohio , May 11, 2015  Through a well-rounded ... Ohio had a strong showing at AUVSI,s Unmanned ... These representatives of Ohio,s UAS industry ... and abroad from all points along the UAS ecosystem. ... Development Coalition,s (DDC) Vice President for Aerospace Rich Knoll ...
(Date:5/10/2015)... GOTHENBURG, Sweden , May 11, 2015 ... touch fingerprint sensors FPC1025 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... the sensors will be used by smartphone manufacturers in ... is included in the communicated revenue guidance of + 1 000 ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
(Date:5/21/2015)... Specialty Pharmacy Times has completed its ... BPA Worldwide as a business publication member. As ... for Specialty Pharmacy Times based on business/distribution, demographics ... member of BPA Worldwide, Specialty Pharmacy Times shows ... the most reliable, unequaled data,” said Chris Hennessy, ...
(Date:5/21/2015)... 21, 2015  The EveryLife Foundation for Rare ... and Amy Klobuchar (D-MN) today for ... & Treatments, or OPEN ACT. Supported ... organizations, this bipartisan legislation promises to rapidly bring ... rare disease patients by incentivizing drug makers to ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation (NASDAQ: ... company specializing in oncology, today announced positive updated ... with aldoxorubicin for the treatment of unresectable glioblastoma ...  The open-label, multisite trial is designed to investigate ... patients whose tumors have progressed following prior treatment ...
(Date:5/21/2015)... Veolia’s environmental monitoring technology division, ... distribution agreement with VWR to distribute TECTA™ B16, ... than 160 years of experience, VWR, a leading ... and production facilities, has cultivated a value proposition ... to enable science. Endetec’s TECTA™ B16, combines ...
Breaking Biology Technology:Specialty Pharmacy Times Joins BPA Worldwide 2Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2
Cached News: